These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38015442)

  • 21. Remote ischaemic postconditioning: does it protect against ischaemic damage in percutaneous coronary revascularisation? Randomised placebo-controlled clinical trial.
    Carrasco-Chinchilla F; Muñoz-García AJ; Domínguez-Franco A; Millán-Vázquez G; Guerrero-Molina A; Ortiz-García C; Enguix-Armada A; Alonso-Briales JH; Hernández-García JM; de Teresa-Galván E; Jiménez-Navarro MF
    Heart; 2013 Oct; 99(19):1431-7. PubMed ID: 23850844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antianginal therapy before percutaneous coronary intervention.
    Borden WB; Spertus JA; Mushlin AI; Roe MT; McCoy LA; Redberg RF
    Circ Cardiovasc Interv; 2013 Aug; 6(4):436-43. PubMed ID: 23922143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Ranolazine in Patients With Chronic Angina in Patients With and Without Percutaneous Coronary Intervention for Acute Coronary Syndrome: Observations From the MERLIN-TIMI 36 Trial.
    Gutierrez JA; Karwatowska-Prokopczuk E; Murphy SA; Belardinelli L; Farzaneh-Far R; Walker G; Morrow DA; Scirica BM
    Clin Cardiol; 2015 Aug; 38(8):469-75. PubMed ID: 26059896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation).
    Fearon WF; Nishi T; De Bruyne B; Boothroyd DB; Barbato E; Tonino P; Jüni P; Pijls NHJ; Hlatky MA;
    Circulation; 2018 Jan; 137(5):480-487. PubMed ID: 29097450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Achieving Optimal Medical Therapy: Insights From the ORBITA Trial.
    Foley M; Rajkumar CA; Shun-Shin M; Ganesananthan S; Seligman H; Howard J; Nowbar AN; Keeble TR; Davies JR; Tang KH; Gerber R; O'Kane P; Sharp ASP; Petraco R; Malik IS; Nijjer S; Sen S; Francis DP; Al-Lamee R
    J Am Heart Assoc; 2021 Feb; 10(3):e017381. PubMed ID: 33496201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous Coronary Intervention in Patients Without Acute Myocardial Infarction in China: Results From the China PEACE Prospective Study of Percutaneous Coronary Intervention.
    Lu Y; Zhang H; Wang Y; Zhou T; Welsh J; Liu J; Guan W; Li J; Li X; Zheng X; Spertus JA; Masoudi FA; Krumholz HM; Jiang L
    JAMA Netw Open; 2018 Dec; 1(8):e185446. PubMed ID: 30646292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.
    Fearon WF; Zimmermann FM; De Bruyne B; Piroth Z; van Straten AHM; Szekely L; Davidavičius G; Kalinauskas G; Mansour S; Kharbanda R; Östlund-Papadogeorgos N; Aminian A; Oldroyd KG; Al-Attar N; Jagic N; Dambrink JE; Kala P; Angerås O; MacCarthy P; Wendler O; Casselman F; Witt N; Mavromatis K; Miner SES; Sarma J; Engstrøm T; Christiansen EH; Tonino PAL; Reardon MJ; Lu D; Ding VY; Kobayashi Y; Hlatky MA; Mahaffey KW; Desai M; Woo YJ; Yeung AC; Pijls NHJ;
    N Engl J Med; 2022 Jan; 386(2):128-137. PubMed ID: 34735046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.
    Morrow DA; Scirica BM; Karwatowska-Prokopczuk E; Murphy SA; Budaj A; Varshavsky S; Wolff AA; Skene A; McCabe CH; Braunwald E;
    JAMA; 2007 Apr; 297(16):1775-83. PubMed ID: 17456819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Outcomes After Percutaneous Coronary Intervention Among Black and White Patients Treated at US Veterans Affairs Hospitals.
    Kobayashi T; Glorioso TJ; Armstrong EJ; Maddox TM; Plomondon ME; Grunwald GK; Bradley SM; Tsai TT; Waldo SW; Rao SV; Banerjee S; Nallamothu BK; Bhatt DL; Rene AG; Wilensky RL; Groeneveld PW; Giri J
    JAMA Cardiol; 2017 Sep; 2(9):967-975. PubMed ID: 28724126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of clinical outcomes following percutaneous coronary intervention versus optimal medical therapy based on gray-zone fractional flow reserve in stable angina patients with intermediate coronary artery stenosis (COMFORTABLE prospective study): Study protocol for a multicenter randomized controlled trial.
    Kitabata H; Kubo T; Shiono Y; Shimamura K; Ino Y; Tanimoto T; Hayashi Y; Komukai K; Sougawa H; Kimura K; Gohda M; Hashizume T; Obana M; Maeda K; Yamaguchi J; Akasaka T
    Trials; 2019 Jan; 20(1):84. PubMed ID: 30691507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
    Weisz G; Généreux P; Iñiguez A; Zurakowski A; Shechter M; Alexander KP; Dressler O; Osmukhina A; James S; Ohman EM; Ben-Yehuda O; Farzaneh-Far R; Stone GW;
    Lancet; 2016 Jan; 387(10014):136-45. PubMed ID: 26474810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease: The Randomized, Double-blind, Placebo-Controlled ISAR-PLASTER Phase 2 Trial.
    Mayer K; Hein-Rothweiler R; Schüpke S; Janisch M; Bernlochner I; Ndrepepa G; Sibbing D; Gori T; Borst O; Holdenrieder S; Kupka D; Petzold T; Bradaric C; Okrojek R; Leistner DM; Trippel TD; Münzel T; Landmesser U; Pieske B; Zeiher AM; Gawaz MP; Hapfelmeier A; Laugwitz KL; Schunkert H; Kastrati A; Massberg S
    JAMA Cardiol; 2021 Jul; 6(7):753-761. PubMed ID: 33787834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rethinking revascularization in patients with stable angina.
    Harskamp RE; Park DW
    Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):159-161. PubMed ID: 29338462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five-Year Outcomes with PCI Guided by Fractional Flow Reserve.
    Xaplanteris P; Fournier S; Pijls NHJ; Fearon WF; Barbato E; Tonino PAL; Engstrøm T; Kääb S; Dambrink JH; Rioufol G; Toth GG; Piroth Z; Witt N; Fröbert O; Kala P; Linke A; Jagic N; Mates M; Mavromatis K; Samady H; Irimpen A; Oldroyd K; Campo G; Rothenbühler M; Jüni P; De Bruyne B;
    N Engl J Med; 2018 Jul; 379(3):250-259. PubMed ID: 29785878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of Life After Fractional Flow Reserve-Guided PCI Compared With Coronary Bypass Surgery.
    Fearon WF; Zimmermann FM; Ding VY; Zelis JM; Piroth Z; Davidavicius G; Mansour S; Kharbanda R; Östlund-Papadogeorgos N; Oldroyd KG; Wendler O; Reardon MJ; Woo YJ; Yeung AC; Pijls NHJ; De Bruyne B; Desai M; Hlatky MA;
    Circulation; 2022 May; 145(22):1655-1662. PubMed ID: 35369704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial.
    Wilson SR; Scirica BM; Braunwald E; Murphy SA; Karwatowska-Prokopczuk E; Buros JL; Chaitman BR; Morrow DA
    J Am Coll Cardiol; 2009 Apr; 53(17):1510-6. PubMed ID: 19389561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De-escalation of antianginal medications after successful chronic total occlusion percutaneous coronary intervention: Frequency and relationship with health status.
    Qintar M; Hirai T; Arnold SV; Sheehy J; Sapontis J; Jones P; Tang Y; Lombardi W; Karmpaliotis D; Moses J; Patterson C; Nicholson WJ; Cohen DJ; Spertus JA; Grantham JA; Salisbury AC
    Am Heart J; 2019 Aug; 214():1-8. PubMed ID: 31152872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Sodium Tanshinone IIA Sulfonate in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Controlled, Randomized Trial.
    Mao S; Wang L; Zhao X; Guo L; Lin Q; Wang X; Dai X; Shang H; Zhang M; Hinek A
    Cardiovasc Drugs Ther; 2021 Apr; 35(2):321-329. PubMed ID: 32940893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial.
    Xu B; Tu S; Song L; Jin Z; Yu B; Fu G; Zhou Y; Wang J; Chen Y; Pu J; Chen L; Qu X; Yang J; Liu X; Guo L; Shen C; Zhang Y; Zhang Q; Pan H; Fu X; Liu J; Zhao Y; Escaned J; Wang Y; Fearon WF; Dou K; Kirtane AJ; Wu Y; Serruys PW; Yang W; Wijns W; Guan C; Leon MB; Qiao S; Stone GW;
    Lancet; 2021 Dec; 398(10317):2149-2159. PubMed ID: 34742368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Routine Fractional Flow Reserve Measurement After Percutaneous Coronary Intervention.
    van Bommel RJ; Masdjedi K; Diletti R; Lemmert ME; van Zandvoort L; Wilschut J; Zijlstra F; de Jaegere P; Daemen J; van Mieghem NM
    Circ Cardiovasc Interv; 2019 May; 12(5):e007428. PubMed ID: 31018666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.